{
    "clinical_study": {
        "@rank": "147824", 
        "acronym": "CONTRA", 
        "arm_group": [
            {
                "arm_group_label": "1", 
                "arm_group_type": "Experimental", 
                "description": "Peginterferon alfa-2a + ribavirin in normal ALT"
            }, 
            {
                "arm_group_label": "2", 
                "arm_group_type": "Active Comparator", 
                "description": "peginterferon alfa-2a + ribavirin in elevated ALT"
            }
        ], 
        "brief_summary": {
            "textblock": "In the current practice patients with normal levels of ALT were not treated. However, a\n      percentage of patients will present an advanced grade of fibrosis and cirrhosis.\n\n      Another reason to treat is the similar response to the treatment than elevated ALT patients\n      published recently in mono-infected patients.\n\n      The investigators have not data concerning the evolution and response to the treatment in\n      co-infected patients with normal ALT.\n\n      In the story of treatment chronic hepatitis C of co-infected patients HCV/HIV, sometimes, it\n      assumes a behavior similar between mono and co-infected patients and the results are\n      different.\n\n      In the case of normal ALT the investigators do not know if the natural history in\n      co-infected patients is similar than the mono-infected patients, and also the response of\n      the treatment.\n\n      This study prospective and controls is the answer of this question. The main hypothesis is\n      if the response of treatment in co-infected patients is not inferior than mono-infected\n      patients.\n\n      The objective is to evaluate the efficacy and safety of peginterferon alfa-2a and ribavirin\n      in HIV positive patients with chronic hepatitis and persistently normal ALT. Every CASE\n      (patient with normal ALT) will have a CONTROL (patient with elevated ALT), concerning\n      genotype, gender and hospital."
        }, 
        "brief_title": "Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients", 
        "completion_date": {
            "#text": "June 2011", 
            "@type": "Actual"
        }, 
        "condition": "Chronic Hepatitis C", 
        "condition_browse": {
            "mesh_term": [
                "Acquired Immunodeficiency Syndrome", 
                "HIV Infections", 
                "Hepatitis", 
                "Hepatitis A", 
                "Hepatitis, Chronic", 
                "Hepatitis C", 
                "Hepatitis C, Chronic"
            ]
        }, 
        "detailed_description": {
            "textblock": "The treatment of co-infected patients with normal ALT would be very important because the\n      evolution of cirrhosis in this patients is quicker and frequently than mono-infected\n      patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients over 18 years old\n\n          -  Hepatitis C co infected with stable HIV-1 and normal ALT (CASE) or elevated levels of\n             ALT (CONTROL)\n\n          -  CD4 > 200 cel/mL\n\n          -  Stable anti-retroviral treatment for HIV during at least, the 6 previous months to\n             the inclusion\n\n          -  Negative contraception test\n\n          -  Informed consent signed\n\n        Exclusion Criteria:\n\n          -  Pregnancy\n\n          -  Any previous treatment for CHC\n\n          -  Any experimental treatment in the 6 previous weeks to the inclusion\n\n          -  Cirrhosis grade B or C (Child-Pugh)\n\n          -  Treatment with colony-stimulating factors, didanosine or zidovudine, immunomodulator\n             therapy, isoniazid, rifampicin, \u2026\n\n          -  Hepatic cancer\n\n          -  Neutrophils < 1500 cel/mL, Platelets < 70000 cel/mL, Hemoglobin < 11 g/dL (men) or <\n             12 g/dL (women) previous to inclusion\n\n          -  Severe psychiatric illness background\n\n          -  Serum creatinin > 1,5 times the upper normal limit\n\n          -  Background of Pulmonary or Cardiovascular disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 11, 2010", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01684787", 
            "org_study_id": "Miguel Sant\u00edn"
        }, 
        "intervention": [
            {
                "arm_group_label": "1", 
                "description": "peginterferon alfa-2a 180 mcg/weekly ribavirin 1000-1200 mg/daily", 
                "intervention_name": "Peginterferon alfa-2a + ribavirin in normal ALT", 
                "intervention_type": "Drug", 
                "other_name": "Pegasys + ribavirin"
            }, 
            {
                "arm_group_label": "2", 
                "description": "peginterferon alfa-2a 180 mcg/weekly ribavirin 1000-1200 mg/daily", 
                "intervention_name": "Peginterferon alfa-2a + ribavirin in elevated ALT", 
                "intervention_type": "Drug", 
                "other_name": "Pegasys + ribavirin"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ribavirin", 
                "Peginterferon alfa-2a", 
                "Interferon-alpha"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "chronic hepatitis C", 
            "normal ALT", 
            "HIV/HCV patients"
        ], 
        "lastchanged_date": "September 12, 2012", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Vitoria", 
                        "country": "Spain", 
                        "state": "Alava", 
                        "zip": "01009"
                    }, 
                    "name": "Hospital de Txagorritxu"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hospitalet", 
                        "country": "Spain", 
                        "state": "Barcelona", 
                        "zip": "08907"
                    }, 
                    "name": "Hospital Universitari of Bellvitge"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hospitalet", 
                        "country": "Spain", 
                        "state": "Barcelona", 
                        "zip": "08907"
                    }, 
                    "name": "Consorci Sanitari Integral"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Matar\u00f3", 
                        "country": "Spain", 
                        "state": "Barcelona", 
                        "zip": "08304"
                    }, 
                    "name": "Hospital General de Matar\u00f3"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Terrassa", 
                        "country": "Spain", 
                        "state": "Barcelona", 
                        "zip": "08227"
                    }, 
                    "name": "Consorci Sanitari de Terrassa"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Sebasti\u00e1n", 
                        "country": "Spain", 
                        "state": "Guip\u00fazcoa", 
                        "zip": "20014"
                    }, 
                    "name": "Hospital de Donostia"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vigo", 
                        "country": "Spain", 
                        "state": "Pontevedra", 
                        "zip": "36204"
                    }, 
                    "name": "Hospital Xeral-C\u00edes"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baracaldo", 
                        "country": "Spain", 
                        "state": "Vizcaya", 
                        "zip": "48903"
                    }, 
                    "name": "Hospital de Cruces"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08036"
                    }, 
                    "name": "Hospital Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08003"
                    }, 
                    "name": "Hospital del Mar"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08025"
                    }, 
                    "name": "Hospital Santa Creu i Sant Pau"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Huesca", 
                        "country": "Spain", 
                        "zip": "22004"
                    }, 
                    "name": "Hospital San Jorge"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28041"
                    }, 
                    "name": "Hospital 12 de Octubre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28006"
                    }, 
                    "name": "Hospital de la Princesa"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28034"
                    }, 
                    "name": "Hospital Ram\u00f3n y Cajal"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28040"
                    }, 
                    "name": "Hospital Cl\u00ednico San Carlos"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tarragona", 
                        "country": "Spain", 
                        "zip": "43007"
                    }, 
                    "name": "Hospital Joan XXIII"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zaragoza", 
                        "country": "Spain", 
                        "zip": "50009"
                    }, 
                    "name": "Hospital Cl\u00ednico Lozano Blesa"
                }
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "Open Multicentre, Phase IV Study to Evaluate Efficacy and Safety of Pegylated Interferon Alpha-2a (40 KD) Plus Ribavirin for Chronic Hepatitis C With Normal Transaminases in Human Immunodeficiency Virus-infected Patients", 
        "overall_official": {
            "affiliation": "Hospital Universitari of Bellvitge", 
            "last_name": "Miguel Santin, Dr", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Spain: Spanish Agency of Medicines", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "% patients with RNA-HCV negative", 
            "safety_issue": "No", 
            "time_frame": "24 weeks after treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01684787"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hospital Universitari de Bellvitge", 
            "investigator_full_name": "Miguel Santin", 
            "investigator_title": "Dr", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "Hospital Universitari de Bellvitge", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Miguel Santin", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2006", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}